Webinar: Anti-MAG Peripheral Neuropathy: An Overview with Richard Lewis, MD
Anti-MAG peripheral neuropathy (Immunoglobulin M(IgM) Anti-Myelin Associated Glycoprotein Peripheral Neuropathy) is a rare autoimmune variety of peripheral neuropathy. In this type of PN, a person’s own immune system attacks cells that are specific in maintaining a healthy peripheral nervous system. As these cells are destroyed by antibodies, they lose function and create problems in both sensory and motor function.
The Foundation for Peripheral Neuropathy is pleased to welcome Richard Lewis, MD, from Cedars-Sinai Medical Center to present on this rare form of neuropathy. In this program, Dr. Lewis will provide a scientific overview of anti-MAG PN, from diagnosis to treatment and everything in between.
Webinar held live June 27, 2022.
From Our Blog...
FPN Funding Contributes $90,000 to IMAGiNe Study for anti-MAG Research
Through the generosity of our donors, we’re able to support the IMAGiNe study with a $150,000 research grant to fund new patient enrollment. $90,000 of
Anti-MAG Peripheral Neuropathy: Q&A
Anti-MAG peripheral neuropathy (Immunoglobulin M(IgM) Anti-Myelin Associated Glycoprotein Peripheral Neuropathy) is a rare autoimmune variety of peripheral neuropathy. In this type of PN, a person’s
CLINICAL HIGHLIGHTS: PNS Meeting 2022
The Peripheral Nerve Society Annual Meeting was held in Miami in May 2022. The Foundation for Peripheral Neuropathy is pleased to be able to provide
Research Study Back on Track!
Following over a year’s delay due to the COVID-19 pandemic, the IMAGiNe Study is finally back on track! The IMAGiNe Study (Immunoglobulin M(IgM)-Anti-myelin-associated-glycoprotein (MAG) Peripheral Neuropathy Study) is a
IMAGiNe Study on anti-MAG IgM paraprotein-associated peripheral neuropathy expanding in the U.S.
The Foundation for Peripheral Neuropathy (FPN) is pleased to announce a new partnership to further research on anti-MAG IgM paraprotein-associated peripheral neuropathy. FPN will be
